Current methods for assembling biosynthetic pathways in microorganisms require a process of repeated trial and error and have long design-build-test cycles. We describe the use of a cell-free transcription-translation (TX-TL) system as a biomolecular breadboard for the rapid engineering of the 1,4-butanediol (BDO) pathway. We demonstrate the reliability of TX-TL as a platform for engineering biological systems by undertaking a careful characterization of its transcription and translation capabilities and provide a detailed analysis of its metabolic output. Using TX-TL to survey the design space of the BDO pathway enables rapid tuning of pathway enzyme expression levels for improved product yield. Leveraging TX-TL to screen enzyme variants for improved catalytic activity accelerates design iterations that can be directly applied to in vivo strain development.
IntroductionUtilizing fast-growing microorganisms to produce molecules of industrial relevance has the potential to rapidly advance the progress of green chemistry. Processes of traditional chemical synthesis require heavy metal catalysts, toxic solvents, and fossil fuels as feedstocks. The biosynthetic approach, which uses naturally occurring enzymes, less energy, and renewable feedstocks, is becoming an attractive alternative. 1-2 However, biosynthetic approaches are challenged by long design-build-test cycles. Microbial pathway engineering often has about oneweek cycle time. 3 The performance of the pathway is frequently far from design, requiring many iterations. 4 For example, it took DuPont and Genencor more than 100 person-years of work to develop the commercialization of biobased 1,3-propanediol. 5 Recent advances in cell-free systems offer an alternative to this costly approach. Cell-free systems have been used to reduce the cycle time of pathway construction. The design-build-test cycle in a cell-free system using linear DNA takes less than one day. 6